LexDanaLexDanabeta
Inventor

Jeffery A. Zablocki

Inventor
Skokie, IL, US

Overview

24→
Patents
1993–2004
Patent span
Chemistry
Primary field (CPC C)

Patents· 24 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds27%
C07CAcyclic or carbocyclic compounds22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
A61KPreparations for medical, dental or toiletry purposes12%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
C07KPeptides8%
G08GTraffic control systems2%
PatentTitleYear
6,794,396'Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity'20046,790,958'Purine inhibitors of cyclin dependent kinase 2 & IKBA'20046,673,788'Electrophilic ketones for the treatment of herpesvirus infections'20046,673,784'Electrophilic ketones for the treatment of herpesvirus infections'20046,605,634'Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents'20036,605,624'Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity'20036,440,973'Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents'20026,420,385'Substituted pyrimidinone and pyridone compounds and methods of use'20026,180,643'Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents'20016,132,697'Radiopharmaceutical compositions capable of localizing at sites of thrombus'20005,973,003'Substituted .beta.-amino acid derivatives useful as platelet aggregation inhibitors'19995,721,366'Platelet aggregation inhibitors'19985,703,125'Substituted .beta.-amino acid derivatives useful as platelet aggregation inhibitors'19975,550,159'Peptide mimics useful as platelet aggregation inhibitors'19965,481,021'Phenyl amidines derivatives useful as platelet aggregation inhibitors'19965,453,440'Peptide mimics useful as platelet aggregation inhibitors'19955,378,727'Substituted bicyclic heterocyclic compounds useful as platelet aggregation inhibitors'19955,354,738'Platelet aggregation inhibitors'19945,344,837'Platelet aggregation inhibitors'19945,344,957'Substituted .beta.-amino acid derivatives useful as platelet aggregation inhibitors'19945,272,162'Platelet aggregation inhibitors'19935,254,573'Substituted heterocyclic derivatives useful as platelet aggregation inhibitors'19935,239,113'Substituted .beta.-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof'19935,220,050'Peptide mimetic compounds useful as platelet aggregation inhibitors'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–2004Patents assigned to SEARLE & CO (17)· patent assignee history
1993–1997Patents assigned to MONSANTO CO (6)· patent assignee history
1993–1999Based in Skokie, IL, US· patent location history
1996–1998Based in Mount Prospect, IL, US· patent location history
2000–2004Based in Lafayette, CO, US· patent location history
2001–2003Patents assigned to AMGEN INC (4)· patent assignee history
2001–2004Based in Mountain View, CA, US· patent location history
2003–2004Patents assigned to PHARMACIA CORP (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SEARLE & CO171993–2004
MONSANTO CO61993–1997
AMGEN INC42001–2003
PHARMACIA CORP22003–2004
Locations
LocationPatentsSpan
Skokie, Illinois, US121993–1999
Mountain View, California, US62001–2004
Lafayette, CO, US42000–2004
Mount Prospect, Illinois, US21996–1998